Patents by Inventor Frederic Tangy

Frederic Tangy has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Dengue and West Nile viruses proteins and genes coding the foregoing, and their use in vaccinal, therapeutic and diagnostic applications
    Publication number: 20060073164
    Abstract: The present invention relates to the development of viral vectors expressing different immunogens from the West Nile Encephalitis Virus (WNV) or the Dengue virus which are able to induce protective humoral and cellular immune responses against WNV or Dengue virus infections. More specifically, the present invention relates to three (3) antigens from WNV (the secreted envelope glycoprotein (E), the heterodimer glycoproteins (pre-M-E) and the NSI protein) and from Dengue virus (the secreted envelope glycoprotein (e), the heterodimer glycoproteins (pre- m-e) and the nsl protein) and their use in vaccinal, therapeutic and diagnostic applications.
    Type: Application
    Filed: August 25, 2005
    Publication date: April 6, 2006
    Inventors: Frederic Tangy, Philippe Despres, Chantal Combredet, Marie Frenkiel
  • Recombinant measles viruses expressing epitopes of antigens of RNA viruses - use for the preparation of vaccine compositions
    Publication number: 20060013826
    Abstract: The invention relates to a recombinant measles virus expressing a heterologous amino acid sequence derived from an antigen of a determined RNA virus, said recombinant measles virus being capable of eliciting a humoral and/or cellular immune response against measles virus or against said RNA virus or against both measles virus and against said RNA virus. It also relates to the use of said recombinant measles virus for the preparation of immunogenic composition.
    Type: Application
    Filed: December 20, 2004
    Publication date: January 19, 2006
    Inventors: Frederic Tangy, Clarisse Lorin, Lucile Mollet, Frederic Delebecque
  • Infectious cDNA of an approved vaccine strain of measles virus, use for immunogenic compositions
    Publication number: 20050227224
    Abstract: The invention relates to a cDNA molecule which encodes the nucleotide sequence of the full length antigenomic (+)RNA strand of a measles virus (MV) originating from an approved vaccine strain. It also concerns the preparation of immunogenic compositions using said cDNA.
    Type: Application
    Filed: December 17, 2004
    Publication date: October 13, 2005
    Inventors: Frederic Tangy, Chantal Combredet, Valerie Labrousse-Najburg, Michel Brahic